{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:09:26Z","timestamp":1762866566156},"reference-count":49,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31070819","31270984"],"award-info":[{"award-number":["31070819","31270984"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Special Fund of Chongqing Key Laboratory (CSTC)"},{"name":"Foundation of National Key Discipline in Laboratory Medicine","award":["2010302"],"award-info":[{"award-number":["2010302"]}]},{"name":"Scientific and Technological Research Program of Chongqing Municipal Education Commission","award":["KJ120318"],"award-info":[{"award-number":["KJ120318"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.vaccine.2015.01.013","type":"journal-article","created":{"date-parts":[[2015,1,14]],"date-time":"2015-01-14T12:01:33Z","timestamp":1421236893000},"page":"1008-1016","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Compound 48\/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice"],"prefix":"10.1016","volume":"33","author":[{"given":"Lingbin","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenchun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.01.013_bib0250","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0255","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2471\/BLT.08.052753","article-title":"The global epidemiology of childhood pneumonia 20 years on","volume":"86","author":"Scott","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0260","doi-asserted-by":"crossref","first-page":"e27333","DOI":"10.1371\/journal.pone.0027333","article-title":"Burden of pneumonia and meningitis caused by Streptococcus pneumoniae in China among children under 5 years of age: a systematic literature review","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0265","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1128\/IAI.05801-11","article-title":"Novel protein-based pneumococcal vaccines administered with the Th1-promoting adjuvant IC31 induce protective immunity against pneumococcal disease in neonatal mice","volume":"80","author":"Olafsdottir","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0270","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12275-014-3583-5","article-title":"Serotype-independent protection against pneumococcal infections elicited by intranasal immunization with ethanol-killed pneumococcal strain, SPY1","volume":"52","author":"Xu","year":"2014","journal-title":"J Microbiol"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0275","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1016\/j.vaccine.2014.05.019","article-title":"Mucosal and systemic immunization with a novel attenuated pneumococcal vaccine candidate confer serotype independent protection against Streptococcus pneumoniae in mice","volume":"32","author":"Wu","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0280","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jps.22759","article-title":"Aluminum adjuvant dose guidelines in vaccine formulation for preclinical evaluations","volume":"101","author":"Vecchi","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0285","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0264-410X(02)00579-0","article-title":"Experience with registered mucosal vaccines","volume":"21","author":"Dietrich","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0290","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0295","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nri2782","article-title":"Mast cell-orchestrated immunity to pathogens","volume":"10","author":"Abraham","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0300","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/381075a0","article-title":"Critical protective role of mast cells in a model of acute septic peritonitis","volume":"381","author":"Echtenacher","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0305","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nm1757","article-title":"Mast cell activators: a new class of highly effective vaccine adjuvants","volume":"14","author":"McLachlan","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0310","doi-asserted-by":"crossref","first-page":"e16532","DOI":"10.1371\/journal.pone.0016532","article-title":"Mucosal targeting of a BoNT\/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT\/A neutralizing antibodies in rabbits","volume":"6","author":"Staats","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0315","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jps.22742","article-title":"Stable dry powder formulation for nasal delivery of anthrax vaccine","volume":"101","author":"Wang","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0320","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.vaccine.2013.01.012","article-title":"A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen","volume":"31","author":"Gwinn","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0325","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1016\/j.vaccine.2009.03.069","article-title":"The mast cell activator compound 48\/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen","volume":"27","author":"McGowen","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0330","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1039\/C2MD20073B","article-title":"A mast cell degranulation screening assay for the identification of novel mast cell activating agents","volume":"4","author":"Woong\u00e1Choi","year":"2013","journal-title":"MedChemComm"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0335","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0091-6749(73)90128-0","article-title":"Histologic studies of human skin test responses to ragweed, compound 4880, and histamine","volume":"51","author":"Atkins","year":"1973","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0340","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0091-6749(88)90011-5","article-title":"Analysis of compound 4880-induced skin histamine release and leukotriene production in chronic urticaria","volume":"82","author":"Brunet","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0345","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1128\/IAI.00240-13","article-title":"Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae","volume":"81","author":"Kong","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0350","doi-asserted-by":"crossref","first-page":"e19863","DOI":"10.1371\/journal.pone.0019863","article-title":"Intranasal immunization with recombinant HA and mast cell activator C48\/80 elicits protective immunity against 2009 pandemic H1N1 influenza in mice","volume":"6","author":"Meng","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0355","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1016\/j.vaccine.2010.08.002","article-title":"TLR-based immune adjuvants","volume":"29","author":"Steinhagen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-4889(01)00182-3","article-title":"Toll-like receptors as adjuvant receptors","volume":"1589","author":"Kaisho","year":"2002","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"10.1016\/j.vaccine.2015.01.013_bib0365","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1086\/591626","article-title":"Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR)2 and TLR4","volume":"198","author":"Klein","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0370","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4049\/jimmunol.170.1.438","article-title":"Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis","volume":"170","author":"Koedel","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0375","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/j.1462-5822.2005.00578.x","article-title":"Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice","volume":"7","author":"Albiger","year":"2005","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0380","doi-asserted-by":"crossref","first-page":"7718","DOI":"10.1128\/IAI.73.11.7718-7726.2005","article-title":"Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model","volume":"73","author":"van Rossum","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0385","doi-asserted-by":"crossref","first-page":"15440","DOI":"10.1073\/pnas.0406740101","article-title":"A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses","volume":"101","author":"Jackson","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0390","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1021\/mp300257x","article-title":"Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice","volume":"9","author":"Tan","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0395","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1016\/j.vaccine.2011.06.105","article-title":"TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors","volume":"29","author":"Cheng","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0400","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/381077a0","article-title":"Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-\u03b1","volume":"381","author":"Malaviya","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0405","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.4049\/jimmunol.0900802","article-title":"Human lung mast cells mediate pneumococcal cell death in response to activation by pneumolysin","volume":"184","author":"Cruse","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0410","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.chom.2011.01.007","article-title":"TH17-based vaccine design for prevention of Streptococcus pneumoniae colonization","volume":"9","author":"Moffitt","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0415","doi-asserted-by":"crossref","first-page":"e1000159","DOI":"10.1371\/journal.ppat.1000159","article-title":"Interleukin-17A mediates acquired immunity to pneumococcal colonization","volume":"4","author":"Lu","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0420","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1128\/IAI.72.10.5807-5813.2004","article-title":"Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization","volume":"72","author":"McCool","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0425","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.4049\/jimmunol.173.7.4576","article-title":"An important role for polymeric Ig receptor-mediated transport of IgA in protection against Streptococcus pneumoniae nasopharyngeal carriage","volume":"173","author":"Sun","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0430","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.4049\/jimmunol.1000831","article-title":"Secretory-IgA antibodies play an important role in the immunity to Streptococcus pneumoniae","volume":"185","author":"Fukuyama","year":"2010","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2015.01.013_bib0435","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.4049\/jimmunol.141.6.2000","article-title":"Human recombinant IL-4 induces activated B lymphocytes to produce IgG and IgM","volume":"141","author":"Defrance","year":"1988","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2015.01.013_bib0440","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/intimm\/3.6.599","article-title":"Regulation of murine in vivo IgG and IgE responses by a monoclonal anti-IL-4 receptor antibody","volume":"3","author":"Finkelman","year":"1991","journal-title":"Int Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2015.01.013_bib0445","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/eji.1830260915","article-title":"In interleukin-4-deficient mice: alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production","volume":"26","author":"Brewer","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0450","doi-asserted-by":"crossref","first-page":"10638","DOI":"10.1073\/pnas.1002348107","article-title":"Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax","volume":"107","author":"Datta","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0455","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0065-2776(08)60866-4","article-title":"Antibody class switching","volume":"61","author":"Stavnezer","year":"1996","journal-title":"Adv Immunol"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0460","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.4049\/jimmunol.170.5.2488","article-title":"IL-13 is necessary, not simply sufficient, for epicutaneously induced Th2 responses to soluble protein antigen","volume":"170","author":"Herrick","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0465","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.4049\/jimmunol.1201212","article-title":"IL-33-mediated innate response and adaptive immune cells contribute to maximum responses of protease allergen-induced allergic airway inflammation","volume":"190","author":"Kamijo","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0470","doi-asserted-by":"crossref","first-page":"755","DOI":"10.4049\/jimmunol.173.2.755","article-title":"Cholera toxin prevents Th1-mediated autoimmune disease by inducing immune deviation","volume":"173","author":"Su","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0475","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.4049\/jimmunol.155.10.4621","article-title":"Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4","volume":"155","author":"Marinaro","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0480","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4049\/jimmunol.153.2.647","article-title":"Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin","volume":"153","author":"Snider","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0485","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.0105-2896.2005.00279.x","article-title":"Rapidly changing perspectives about mast cells at mucosal surfaces","volume":"206","author":"Vliagoftis","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2015.01.013_bib0490","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1084\/jem.188.9.1587","article-title":"Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice","volume":"188","author":"Choi","year":"1998","journal-title":"J Exp Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15000328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15000328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T23:44:55Z","timestamp":1690847095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15000328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0264410X15000328"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.01.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Compound 48\/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}